A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus
Applied Biochemistry and Biotechnology · 2024
DOI: 10.1007/s12010-023-04604-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2024. Verfasst von Zeeshan Ali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Krupanidhi College of Physiotherapy, Bangalore, Karnataka, 560035, India. Hauptthemen laut MEDLINE: Viral Vaccines, Hemorrhagic Fever, American. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Bolivian hemorrhagic fever (BHF) caused by Machupo virus (MACV) is a New World arenavirus having a reported mortality rate of 25-35%. The BHF starts with fever, followed by headache, and nausea which rapidly progresses to severe hemorrhagic phase within 7 days of disease onset. One of the key promoters for MACV viral entry into the cell followed by viral propagation is performed by the viral glycoprotein (GPC). GPC is post-transcriptionally cleaved into GP1, GP2 and a signal peptide. These proteins all take part in the viral infection in host body. Therefore, GPC protein is an ideal target for developing therapeutics against MACV infection. In this study, GPC protein was considered to design a multi-epitope, multivalent vaccine containing antigenic and immunogenic CTL and HTL epitopes. Different structural validations and physicochemical properties were analysed to validate the vaccine. Docking and molecular dynamics simulations were conducted to understand the interactions of the vaccine with various immune receptors. Finally, the vaccine was codon optimised in silico and along with which immune simulation studies was performed in order to evaluate the vaccine's effectiveness in triggering an efficacious immune response against MACV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Krupanidhi College of Physiotherapy, Bangalore, Karnataka, 560035, India.
- REVA University, Bangalore, India.
- Independent Researcher, Bangalore, India.
- Military Institute of Engineering, Rio de Janerio, Brazil.
- INRS - Centre Armand-Frappier Santé Biotechnologie, Université de Québec, Laval, Québec, H7V 1B7, Canada.
- University of Hradec Kralove, Hradec Kralove, Czech Republic.
Zitieren
APA
Ali, Z., Cardoza, J. V., Basak, S., Narsaria, U., Bhattacharjee, S., G, U. M., Isaac, S. P., Franca, T. C. C., LaPlante, S. R., & George, S. S. (2024). A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-023-04604-9
Vancouver
Ali Z, Cardoza JV, Basak S, Narsaria U, Bhattacharjee S, G UM, et al. A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus. Applied Biochemistry and Biotechnology. 2024. doi:10.1007/s12010-023-04604-9
BibTeX
@article{Ali2024,
author = {Ali, Zeeshan and Cardoza, Jyothsna Volisha and Basak, Srijita and Narsaria, Utkarsh and Bhattacharjee, Surjit and G, Unnati Meher and Isaac, Samuel Paul and Franca, Tanos C C and LaPlante, Steven R and George, Sudhan S},
title = {A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus},
journal = {Applied Biochemistry and Biotechnology},
year = {2024},
doi = {10.1007/s12010-023-04604-9}
}
EUVIMED